TNM classification
Prognostic significance of the 8th edition of the TNM classification for patients with extensive disease small cell lung cancer
9
Prognostic value of the seventh AJCC/UICC TNM classification of non cardia gastric cancer
7
Neuroendocrine tumors of the pancreas: a retrospective single-center analysis using the ENETS TNM-classification and immunohistochemical markers for risk stratification
10
Original Article Expression of circular RNA circASXL1 correlates with TNM classification and predicts overall survival in bladder cancer
8
Original Article Questioning the staging of tumor deposits of colorectal cancer in the eighth edition of the TNM classification: validation by prognosis
10
Efficacy of Postoperative Adjuvant Chemotherapy According to Prognostic Factor in Patients with Stage III Colon Cancer
12
DNA methylation-based classification and identification of renal cell carcinoma prognosis-subgroups
14
Selection of candidates for surgery as local therapy among early-stage small cell lung cancer patients: a population-based analysis
11
Outcomes of implant-based oral rehabilitation in head and neck oncology patients—a retrospective evaluation of a large, single regional service cohort
12
Comparing clinicopathological features and prognosis of primary pulmonary invasive mucinous adenocarcinoma based on computed tomography findings
8
Original Article High expression of N-acetyltransferase 10: a novel independent prognostic marker of worse outcome in patients with hepatocellular carcinoma
7
DNA methylation-based classification and identification of bladder cancer prognosis-associated subgroups
11
Multi Factorial Functional Analysis of the Patients with Reconstruction for Oral Carcinoma
9
Pretreatment platelet count improves the prognostic performance of the TNM staging system and aids in planning therapeutic regimens for nasopharyngeal carcinoma: a single-institutional study of 2,626 patients
10
ABCG2/V-ATPase was associated with the drug resistance and tumor metastasis of esophageal squamous cancer cells
7
Evaluation of the new TNM staging system for thymic malignancies: impact on indication and survival
8
TNM-O: ontology support for staging of malignant tumours
11
The combination of dendritic cells-cytotoxic T lymphocytes/cytokine-induced killer (DC-CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumors
12
A three-protein signature and clinical outcome in esophageal squamous cell carcinoma
14
Prognostic significance of tumor budding and single cell invasion in gastric adenocarcinoma
9